Bellerophon Therapeutics在盘前股价暴跌39%,因公司将被纳斯达克摘牌。查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-10 AccNo: 0001600132-18-000057 Size: 3 MB 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001600132-18-000054 Size: 89 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ 8-K - Current report Filed: 2018-04-26 AccNo: 0001600132-18-000050 Size: 60 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-04-16 AccNo: 0001718111-18-000003 Size: 61 KB 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-05 AccNo: 0001600132-18-000048 Size: 375 KB 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-05 AccNo: 0001600132-18-000047 Size: 989 KB 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ 8-K - Current report Filed: 2018-03-26 AccNo: 0001600132-18-000040 Size: 34 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ht...
$Bellerophon Therapeutics, Inc.(BLPH)$ PRE 14A - Other preliminary proxy statements Filed: 2018-03-26 AccNo: 0001600132-18-000038 Size: 959 KB 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ 8-K - Current report Filed: 2018-03-15 AccNo: 0001600132-18-000036 Size: 205 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Bellerophon Therapeutics, Inc.(BLPH)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-15 AccNo: 0001600132-18-000034 Size: 7 MB 网页链接